Nipro PharmaPackaging
Nipro PharmaPackaging is the European pharmaceutical primary packaging arm of Japan's Nipro Corporation, manufacturing glass tubing, vials, pre-fillable syringes, cartridges, and ampoules for injectable and topical drug companies across cardiovascular, oncology, vaccine, and chronic disease therapy areas, with 15 production plants in Europe, the Americas, and Asia.
- Company typePrivate
- Founded1954
- HeadquartersZaventem, Belgium
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nipro PharmaPackaging does
Nipro PharmaPackaging, headquartered at the Nipro Campus in Mechelen, Belgium, is the pharmaceutical primary packaging division of Nipro Corporation Japan. The business is specialized in developing and manufacturing primary packaging for injectable and topical pharmaceutical drugs, operating from glass tubing conversion through to finished containers. Its product portfolio spans pre-fillable glass syringes (D2F system in silicone oil-free, Luer Lock, Luer, and staked needle variants), glass vials (VIALEX with enhanced inner surface durability plus crimp neck, screw neck, and unit-dose formats), ampoules including anti-counterfeit (ACT), double-tip, fine-tip, and Form B/C/D variants, dental and pen cartridges, and a full set of borosilicate and soda lime glass tubing families (eNable NSV51, eNhance, eNgage, G38 amber, W33, NSV51 with Cerium, WG06). The division is vertically integrated, drawing on Type I borosilicate glass expertise inherited from the parent group's 1954 origins as Nihon Glass Shoji Co. Ltd., and supported by 15 production plants across Europe, the Americas, and Asia.
The company monetizes through B2B enterprise sales of pharmaceutical packaging components to drug manufacturers across therapy areas including cardiovascular, oncology, anticoagulation, dental, vaccines, biologics, diabetes, and animal health. Pricing is not publicly disclosed; commercial terms are negotiated under multi-year supply contracts through dedicated sales offices in Europe (Austria, France, Germany, Italy, Netherlands, Poland, Portugal, Spain, UK), the Americas (USA), Asia (India, China, Japan), the Middle East (UAE), and Africa. Distribution is direct, supplemented by industry event presence at CPHI, NIVAS, ISBP, and SFNDT, plus the iMEP training center and a corporate knowledge hub for technical content dissemination.
Beyond primary packaging, the Nipro Europe Group (of which Nipro PharmaPackaging is part) carries dialysis machines and dialyzers (SURDIAL, ELISIO, SUREFLUX, SOLACEA), reverse osmosis water treatment (LiniXia), home infusion (Surefuser+), diabetes monitoring (4SURE Smart), infection control (CLFine), vascular imaging (Makoto IVUS), and SAFETOUCH safety needle lines. Relevant third-party integrations include D2F syringe compatibility with the medmix PiccoJect 100 auto-injector and LiniXia compatibility with Workbench remote supervision software. Certifications include ISO 17025 for the Technical Services Glass Laboratory and 2024 Qualifyze certificates for plants in the USA, Croatia, and France. Recent strategic activity includes a 2026 Rs 200 crore India investment commitment at PULSE 2026, the 2021 Piramida (Croatia) acquisition, and the September 2023 launch of the silicone oil-free D2F pre-fillable syringe.
Nipro PharmaPackaging firmographics
Firmographics- Name
- Nipro PharmaPackaging
- Legal name
- Nipro Europe Group Companies
- Website
- https://nipro-group.com
- Company type
- Private
- Founded year
- 1954
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Nipro PharmaPackaging is the European pharmaceutical primary packaging arm of Japan's Nipro Corporation, manufacturing glass tubing, vials, pre-fillable syringes, cartridges, and ampoules for injectable and topical drug companies across cardiovascular, oncology, vaccine, and chronic disease therapy areas, with 15 production plants in Europe, the Americas, and Asia.
- Ownership category
- akta.pro rank
Nipro PharmaPackaging industry classification
Industry- Product category
- Pharmaceutical Primary Packaging
- NAICS
- Glass Container Manufacturing (327213)
- SIC
- Glass Containers (3221), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA)
- akta.pro secondary industries
- Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB), Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE), Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features) (IMALAIAJ), Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers) (IMALAIAH)
Keywords
Where Nipro PharmaPackaging is headquartered
LocationHeadquarters
- HQ city
- Zaventem
- HQ country
- Belgium
- HQ region
- Europe
Offices24 records
Markets served
Nipro PharmaPackaging business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Packaging Products: Nipro PharmaPackaging generates revenue through manufacturing and selling comprehensive pharma packaging solutions including glass tubing, vials, pre-fillable syringes, cartridges, and ampoules to pharmaceutical companies worldwide.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/B2B pricing for pharmaceutical packaging solutions |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Nipro PharmaPackaging product offering
Product offeringCore offering
Nipro PharmaPackaging manufactures and sells vertically integrated primary pharmaceutical packaging products for drug manufacturers worldwide. The portfolio spans glass tubing (Type I borosilicate and Type III formulations), pre-fillable glass syringes (D2F family with silicone-oil-free variants), glass vials (VIALEX with enhanced inner surface durability, plus crimp neck, screw neck and unit-dose formats), ampoules (including anti-counterfeit technology variants), and dental and pen cartridges for self-administration devices. Products are sold B2B to pharmaceutical companies serving therapy areas such as biologics, vaccines, oncology, cardiovascular, anticoagulation, dental, animal health, and chronic disease self-administration.
Product overview
Nipro PharmaPackaging, established in 1954, is a vertically integrated manufacturer of comprehensive pharmaceutical packaging solutions spanning from glass tubing production to finished primary packaging products. The portfolio includes D2F™ Pre-fillable Glass Syringes (silicone oil-free, Luer Lock, Luer, and staked needle variants), VIALEX™ glass vials with enhanced inner surface durability, ampoules with anti-counterfeit technology, dental and pen cartridges, glass tubing in multiple formulations (eNble, eNhance, eNgage, G38, W33, NSV51 with Cerium, WG06), and medical devices including D2Mix™ vial-to-syringe systems and CURACASE™ hypodermic needles. Nipro PharmaPackaging serves specific therapy areas including cardiovascular emergency drugs, oncology, hematology/anticoagulation, dental, animal health, infectious diseases/vaccines, and chronic disease self-administration. Beyond pharmaceutical packaging, the broader Nipro Group also offers renal care products (LiniXia™ RO water systems, SURDIAL™ dialysis machines, ELISIO™/SUREFLUX™/SOLACEA™ dialyzers), diabetes care devices (4SURE Smart glucose monitors), vascular imaging (Makoto™ Intravascular Imaging System), home infusion (Surefuser+™), infection control (CLFine), and general hospital supplies including SAFETOUCH™ safety needle product lines.
Differentiator
Problem solved
Functional benefit
Brands
- LiniXia™: Reverse-osmosis (RO) water treatment system generating RO permeate for use in dialysis.
- Surefuser+™
- NephroFlow™
- Makoto™
- CLFine
- D2F™
- VIALEX™
- eNable™
- eNgage™
- eNhance™
- D2Mix™
- CURACASE™
- CITRASATE™
- iMEP
- 4SURE™
- ELISIO™
- SUREFLUX™
- SOLACEA™
- SURDIAL™
Products and services
- D2F Pre-fillable Glass Syringe System - Silicone Oil-Free Ready-to-use pre-fillable glass syringe system featuring silicone-oil-free interior coating designed for drug products highly sensitive to silicone oil, providing reliable filling operations and stable storage of standard and complex drug products.
- D2F Pre-fillable Glass Syringes - Luer Lock Ready-to-use pre-fillable glass syringes with Luer Lock connection for reliable filling operations and stable storage of standard and complex drug products.
- D2F Pre-fillable Glass Syringes - Luer Ready-to-use pre-fillable glass syringes with Luer connection format for standard pharmaceutical filling applications.
- D2F Pre-fillable Glass Syringes - Staked Needle Pre-fillable glass syringes with integrated staked needle design for pharmaceutical applications requiring fixed needle administration.
- VIALEX Glass Vials Glass vials featuring high cosmetic and dimensional quality combined with exceptional inner surface durability through VIALEX surface treatment technology.
- Crimp Neck Vials Pharmaceutical vials with crimp neck finish for injectable pharmaceutical applications requiring secure closure.
- Screw Neck Vials Pharmaceutical vials with screw neck finish designed for pharmaceutical applications requiring screw-thread closure systems.
- Unit Dose Vials Single-use pharmaceutical vials designed for unit-dose applications in pharmaceutical fill-finish operations.
- Ampoules with Anti-Counterfeit Technology (ACT) Glass ampoules featuring anti-counterfeiting technology for pharmaceutical brand protection and supply chain security.
- Double Tip Ampoules Glass ampoules with double tip design precisely shaped for pharmaceutical applications requiring easy opening at both ends.
- Fine Tip Ampoules Pharmaceutical ampoules with fine tip design for applications requiring precise dispensing and controlled opening.
- Form B/C/D Ampoules Pharmaceutical ampoules in various form factors (B, C, D) for different pharmaceutical application requirements.
- Dental Cartridges Glass cartridges designed for integration into dental injection devices, made from premium Type I borosilicate glass tubing offering excellent chemical resistance.
- Pen Cartridges Glass cartridges designed for integration into diabetes pen systems for self-administration of pharmaceutical compounds.
- Glass Test Tubes Glass test tubes for laboratory testing applications in pharmaceutical quality control and analysis.
- eNable NSV51 Glass Tubing Premium quality borosilicate glass tubing meeting prevailing quality requirements for pharmaceutical packaging applications.
- eNhance NSV51 Glass Tubing Premium quality glass tubing for the highest quality requirements in pharmaceutical packaging applications.
- eNgage NSV51 Glass Tubing Fully customizable glass tubing for pharmaceutical packaging applications requiring tailored specifications.
- G38 Borosilicate Glass Tubing Amber borosilicate glass tubing Type III with 76 expansion for light-sensitive pharmaceutical applications.
- W33 Borosilicate Glass Tubing Clear borosilicate glass tubing Type I with 33 expansion for pharmaceutical packaging requiring high chemical resistance.
- NSV51 with Cerium Glass Tubing Clear borosilicate glass tubing Type I with cerium addition for pharmaceutical packaging applications requiring radiation protection.
- WG06 Glass Tubing Clear soda lime glass tubing Type III with 93 expansion for non-parenteral pharmaceutical packaging applications.
- CURACASE Hypodermic Needles in Hard Case Unit Pack Hypodermic needles packaged in hard plastic unit pack for pharmaceutical and medical device applications.
- D2Mix Vial-to-Syringe Device enabling connection of a vial to a syringe for drug reconstitution and transfer in pharmaceutical settings.
- D2Mix Vial-to-Vial-to-Syringe Device enabling connection of multiple vials to a syringe for sequential drug transfer and reconstitution applications.
- LiniXia Reverse Osmosis (RO) System Reverse-osmosis water treatment system generating RO permeate for use in dialysis, featuring semi-open design, frequency-controlled pumps, and up to 90% permeate yield.
- Surefuser+ Lightweight single-use elastomeric infusion pump for ambulatory care allowing patients to receive intravenous therapy in the comfort of home.
- NephroFlow Product Suite Complete range of configurable digital modules for dialysis units to adapt to rising digital needs, enabling process-driven dialysis workflow management.
- Makoto Intravascular Imaging System Intravascular imaging system using HF-OCT (high-frequency optical coherence tomography) technology for cardiovascular diagnosis and plaque assessment.
- CLFine Environmental Disinfection Equipment Environmental disinfection equipment that sanitizes air and surfaces through atomized hypochlorous acid (HOCl) mist to inactivate viruses and bacteria.
- 4SURE Smart Blood Glucose Monitor Blood glucose monitoring system with Bluetooth connectivity for diabetes management enabling patients to track and transmit glucose readings.
- ELISIO Dialyzer Dialyzer with polynephron membrane providing maximum versatility for hemodialysis treatment across various patient needs.
- SUREFLUX Dialyzer Dialyzer with cellulose triacetate membrane, ideal for hemodialysis patients sensitive to synthetic membranes.
- SOLACEA Dialyzer Dialyzer with asymmetric triacetate membrane designed for hemodiafiltration (HDF) patients sensitive to synthetic membranes.
- SURDIAL X Hemodialysis Machine High performance hemodialysis machine designed for individually optimized treatments in clinical dialysis settings.
- SURDIAL 55PLUS Hemodialysis Machine High quality hemodialysis machine that is easy to use and cost-effective for standard dialysis treatment.
- SAFETOUCH IV Catheter IV catheter with Nipro's passive safety device for needlestick injury prevention.
- SAFETOUCH Hypodermic Needle Hypodermic needle with easy-to-use safety device for healthcare worker protection against needlestick injuries.
- SAFETOUCH Blood Collection Set Blood collection set with Nipro's safety device for needlestick protection during phlebotomy procedures.
- SAFETOUCH Winged Needle Set Winged needle set with Nipro's safety device combining butterfly design with passive safety mechanism.
- Safetouch Huber Needle Set Huber needle infusion set combining high quality needle with an easy-to-activate safety device for subcutaneous infusion access.
- DOSESAVER Syringe Syringe designed to limit the amount of fluid lost during injection, ensuring accuracy of dose for patients and cost-saving for expensive medications.
- Aperta NSE Scoring Balloon Catheter Scoring balloon catheter for vascular interventions, designed to perform efficiently under high pressure cases.
Companies that use Nipro PharmaPackaging
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Nipro PharmaPackaging technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature5 records
Nipro PharmaPackaging partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Ramky InfrastructurecorePartnership for Bulk Drug Park development in Maharashtra, India under public-private partnership with MIDC. Nipro Pharmapackaging committed Rs 200 crore investment at PULSE 2026 healthcare conference.
- Maharashtra GovernmentcoreMoU signed at PULSE 2026 healthcare conference for Rs 200 crore investment in healthcare sector expansion, including Nipro's manufacturing and operational growth in Maharashtra, India.
- DiaverumcoreNIPRO Partners with Diaverum for the First LiniXia Installation in the UK - Nipro's reverse osmosis water treatment system for dialysis being deployed at Diaverum's UK facilities. This represents a core strategic partnership in the renal care sector.
- Diaverum UKcoreFirst LiniXia installation in the UK at Diaverum facility - Nipro's advanced reverse osmosis water treatment system deployed for dialysis applications.
- Galenova Inc.minorALK-Abelló partnered with Galenova Inc. in June 2023 to secure supply of high-quality glass vials for pharmacies and hospitals across Canada. This indicates Galenova as a distribution partner for pharmaceutical glass products.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Nipro PharmaPackaging competitors and assessment
Company assessmentDirect peers
- Schott AG: Global leader in pharmaceutical glass packaging, including vials, ampoules, syringes and cartridges. Schott's pharma division is the closest direct competitor to Nipro PharmaPackaging across both tubing and converted packaging, with comparable Type I borosilicate offerings.
- Gerresheimer AG: European-headquartered manufacturer of primary packaging for pharma (glass vials, ampoules, syringes, plastic containers). Directly competes with Nipro in vials and ampoules serving global pharma customers.
- Stevanato Group: Italian provider of glass primary packaging and drug containment solutions, including pre-fillable syringes and vials. Closely comparable to Nipro in glass syringes and ready-to-use packaging for biologics.
- West Pharmaceutical Services: US-listed leader in primary packaging for injectable drugs, including stoppers, seals, syringes and cartridge components. Overlaps with Nipro's parenteral and injectable packaging components portfolio.
- SGD Pharma: French manufacturer of molded and tubular glass packaging for pharmaceuticals (vials, bottles, droppers). Comparable product portfolio to Nipro's vials and ampoules in Type I and Type III glass.
- DWK Life Sciences: Global manufacturer of premium laboratory glassware and pharmaceutical primary packaging (vials, ampoules, dropper bottles). Comparable product mix in tubular glass packaging for pharma.
- Bormioli Pharma: Italian producer of glass and plastic primary packaging for pharma, including vials, syringes and bottles. Direct comparable in vials, ampoules and containers for injectable and oral drugs.
Broad incumbents
- Becton, Dickinson and Company (BD): Diversified medical device and pharmaceutical systems company with a large pre-fillable syringe and drug delivery franchise. Competes with Nipro in pre-fillable syringes and combination products, though BD's portfolio is much broader.
- Corning Incorporated: Supplies pharmaceutical glass tubing (Corning Valor) and engineered glass for vials/syringes. A broader glass specialist that overlaps with Nipro's glass tubing and primary container upstream.
Emerging players
- AptarGroup: Specializes in drug delivery systems, dispensing closures and elastomeric components. Adjacent to Nipro in injectable delivery ecosystems (auto-injectors, pen systems), with overlap in drug-delivery device integration.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Nipro PharmaPackaging social profiles
Digital presenceNipro PharmaPackaging compliance and trust
Trust signalCompliance1 record
Nipro PharmaPackaging financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nipro PharmaPackaging leadership team
Management profileNumber of profiles
Profiles1 record
Nipro PharmaPackaging subsidiaries and ownership
Company hierarchySubsidiaries11 records
Nipro PharmaPackaging funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nipro PharmaPackaging M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nipro PharmaPackaging
What does Nipro PharmaPackaging do?
Nipro PharmaPackaging manufactures and sells vertically integrated primary pharmaceutical packaging products for drug manufacturers worldwide. The portfolio spans glass tubing (Type I borosilicate and Type III formulations), pre-fillable glass syringes (D2F family with silicone-oil-free variants), glass vials (VIALEX with enhanced inner surface durability, plus crimp neck, screw neck and unit-dose formats), ampoules (including anti-counterfeit technology variants), and dental and pen cartridges for self-administration devices. Products are sold B2B to pharmaceutical companies serving therapy areas such as biologics, vaccines, oncology, cardiovascular, anticoagulation, dental, animal health, and chronic disease self-administration.
Is Nipro PharmaPackaging a public or private company?
Nipro PharmaPackaging is a private company. It is classified as corporate owned and is currently operating.
When was Nipro PharmaPackaging founded?
Nipro PharmaPackaging was founded in 1954. It employs 1,001 to 5,000 people.
Where is Nipro PharmaPackaging based?
Nipro PharmaPackaging is headquartered in Zaventem, Belgium, in the Europe region.
How does Nipro PharmaPackaging make money?
One revenue line is on record: pharmaceutical Packaging Products.
Who are Nipro PharmaPackaging's main competitors?
Direct peers on record are Schott AG, Gerresheimer AG, Stevanato Group, West Pharmaceutical Services, SGD Pharma, DWK Life Sciences and Bormioli Pharma. Broad incumbents are Becton, Dickinson and Company (BD) and Corning Incorporated. AptarGroup is listed as an emerging player.
Does Nipro PharmaPackaging have an API?
No public API is recorded for Nipro PharmaPackaging.
What industry is Nipro PharmaPackaging in?
Nipro PharmaPackaging's product category is Pharmaceutical Primary Packaging. Its primary akta.pro industry code is IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules), with a secondary code of IMALAEAB, Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes). Its NAICS code is 327213 and its SIC code is 3221.